Pfizer
在场
是其中之一......
- Forbes Global 2000 (#436);
- Fortune 500 (#69);
- Global Fortune 500 (#236);
- Russell 3000;
- S&P 500;
- TOB Iconic 10,000.
Pfizer 是一家在股票代码 PFE (US) 下上市的公司。
Pfizer 在 39 个国家有直接业务。Pfizer 拥有 46家子公司，其中包括 Pfizer Asia、Pfizer Australia 和 Pfizer Austria。
他们在：
涉及Pfizer的并购和融资。
- Pfizer 已收购 Seagen (公布2023十二月12号).
- Pfizer has announced the acquisition of Seagen (公布2023三月13号).
- Pfizer has announced the acquisition of Seagen (公布2023二月27号).
高管
查看带有其 331 名主要高管的组织结构图
Pfizer 搜索最多的简介
- Albert Bourla, Chief Executive Officer and Chairman of the Board
- Scott Gottlieb, Director
- James Smith, Director
高管在Pfizer变化
- Chris Boshoff 曾任 Chief Oncology Research and Development Officer and Executive Vice President, 将于 20251月1 升职为 Chief Scientific Officer and President of Research & Development (新闻发布的2024十一月21号).
- Tim Buckley已作为Director加入公司 (新闻发布的2024十月15号).
- Mikael Dolsten, Chief Scientific Officer and President, Research & Development 请很快离开公司 (新闻发布的2024七月9号).
创建提醒
跟踪 Pfizer 的高管变动
药店
Pfizer 拥有 1,833 家竞争者，其中包括 Johnson & Johnson (美国(美洲))、Sanofi (法国) 和 Roche (瑞士)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十二月5号)..
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
药店 行业的其他推荐联系人
消息
Pfizer 的最新新闻稿
- Pfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences
- Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
- European Commission Approves Pfizer’s ABRYSVO™ to Help Protect Infants through Maternal Immunization and Older Adults from RSV
- U.S. FDA Approves ABRYSVO™, Pfizer’s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Infants Through Active Immunization of Pregnant Individuals 32-36 Weeks of Gestational Age
- Pfizer’s ELREXFIO™ Receives U.S. FDA Accelerated Approval for Relapsed or Refractory Multiple Myeloma
- Pfizer Reports Second-Quarter 2023 Results
- Pfizer Announces Executive Leadership to Advance Oncology Research and Development Strategy
- Pfizer Announces New England Journal of Medicine Publication on Group B Streptococcus (GBS)Maternal Vaccine Candidate
- Pfizer Announces Post-Tornado Relief Plans for Rocky Mount Community and Manufacturing Facility
- Pfizer Provides Update on GLP-1-RA Clinical Development Program for Adults with Obesity and Type 2 Diabetes Mellitus
- View more press releases Close
通过电子邮件
